Repligen shows its net margin is negative at -1.5%, with a gross margin of 53.8%, an operating margin of 2.3%, an EBITDA margin of 15.8%, and a net margin of -1.5%. Gross margin headed the available margin improvements with a 8.1 percentage-point increase, while net margin dropped by 1.7 percentage points.
Over the last 3 years, Repligen recorded average margins of 47.72% gross, 0.61% operating, 18.98% EBITDA, and 1.44% net. Right now, gross and operating margins are above their three-year averages, while EBITDA and net margins are below their three-year averages.
The largest positive change was in gross margin, up 8.1 percentage points. Operating margin also expanded by 3.4 percentage points, while EBITDA margin contracted by 1.3 percentage points and net margin by 1.7 percentage points.
Across the last 3 years, Repligen recorded an average gross margin of 47.72%. Repligen's current gross margin is 53.8% and is 6.1 percentage points above its three-year average. The highest gross margin for Repligen was 53.8% in Sep 2026, while the lowest was 43.3% in Dec 2024.
Over the last 3 years, Repligen's operating margin averaged 0.61%. The current operating margin of 2.3% is 1.7 percentage points above its three-year average. During this period, operating margin reached a high of 7.8% in Jun 2026 and a low of -5% in Dec 2024.
Repligen recorded an average EBITDA margin of 18.98% across the last 3 years. Repligen currently reports an EBITDA margin of 15.8%, 3.2 percentage points below its three-year average. During this period, EBITDA margin reached a high of 24.5% in Dec 2025 and a low of 12.7% in Dec 2024.
Repligen recorded an average net margin of 1.44% across the last 3 years. Repligen currently reports a net margin of -1.5%, 2.9 percentage points below its three-year average. The net margin for Repligen moved between -4% in Dec 2024 and 6.7% in Mar 2026.
Repligen's gross margin of 53.8% is higher than the industry average but lower than the Healthcare sector and its peers average. Looking at the Healthcare sector average of 68.3%, Repligen's gross margin is 21% lower.
The current gross margin for RGEN is 53.8% as of Sep 30, 2026.
The current operating margin for RGEN is 2.3% as of Sep 30, 2026.
The current EBITDA margin for RGEN is 15.8% as of Sep 30, 2026.
As of Sep 30, 2026, RGEN has a negative net margin of -1.5%.
Repligen's average margins over the last 3 years were 47.7% gross, 0.6% operating, 19.0% EBITDA, and 1.4% net.
Repligen's highest recorded margins during the past 5 years were 58.9% gross in Mar 2022, 28% operating in Dec 2022, 34.6% EBITDA in Dec 2022, and 23.2% net in Dec 2022.
In the last 5 years, the lowest margins reported by RGEN were 43.3% gross in Dec 2024, -5% operating in Dec 2024, 12.7% EBITDA in Dec 2024, and -4% net in Dec 2024.